GEOVAX LABS, INC. Stock Issued During Period, Shares, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GEOVAX LABS, INC. stock issued during period, shares, issued for services for the quarter ending 2024-03-31 was 6.70K shares.
- GEOVAX LABS, INC. stock issued during period, shares, issued for services for the quarter ending 2021-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- GEOVAX LABS, INC. stock issued during period, shares, issued for services for the quarter ending 2021-09-30 was 0.00 shares.
- GEOVAX LABS, INC. stock issued during period, shares, issued for services for the quarter ending 2021-06-30 was 12.23K shares, a 71.20% decline year-over-year.
- GEOVAX LABS, INC. stock issued during period, shares, issued for services for fiscal 2023 was 24.02K shares, a 151.08% increase from fiscal 2022.
- GEOVAX LABS, INC. stock issued during period, shares, issued for services for fiscal 2022 was 9.57K shares, a 30.20% decline from fiscal 2021.
- GEOVAX LABS, INC. stock issued during period, shares, issued for services for fiscal 2021 was 13.71K shares, a 48.43% decline from fiscal 2020.
- GEOVAX LABS, INC. stock issued during period, shares, issued for services for fiscal 2020 was 26.58K shares, a 16308.02% increase from fiscal 2019.
| Period end | Stock Issued During Period, Shares, Issued for Services 3 month | Stock Issued During Period, Shares, Issued for Services 12 month |
|---|---|---|
| 2025-12-31 | 5.21K shares S-1 · filed 2026-09-17 | |
| 2024-12-31 | 268.00 shares S-1 · filed 2026-09-17 | |
| 2024-03-31 | 6.70K shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 24.02K shares 10-K · filed 2025-03-27 | |
| 2022-12-31 | 9.57K shares 10-K · filed 2024-02-29 | |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 13.71K shares 10-K · filed 2023-03-23 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 37.13K shares derived: sum of 4 quarters · filed 2022-03-09 |
| 2021-06-30 | 12.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -12.61K shares derived: sum of 4 quarters · filed 2022-03-09 |
| 2021-03-31 | 1.47K shares 10-Q · filed 2021-05-06 | 17.64K shares derived: sum of 4 quarters · filed 2022-03-09 |
| 2020-12-31 | 23.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | 26.58K shares 10-K · filed 2022-03-09 |
| 2020-09-30 | -49.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -38.63K shares derived: sum of 4 quarters · filed 2021-03-23 |
| 2020-06-30 | 42.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 48.93K shares derived: sum of 4 quarters · filed 2021-03-23 |
| 2020-03-31 | 10.42K shares 10-Q · filed 2020-05-05 | 10.58K shares derived: sum of 4 quarters · filed 2021-03-23 |
| 2019-12-31 | -41.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | 162.00 shares 10-K · filed 2021-03-23 |
| 2019-09-30 | 37.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | |
| 2019-06-30 | 4.13K shares 10-Q · filed 2019-08-13 | |
| 2018-12-31 | 17.00 shares 10-K · filed 2020-03-24 | |
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-13 | |
| 2018-03-31 | 5.00M shares 10-Q · filed 2018-05-03 | |
| 2012-12-31 | 0.00 shares 10-K · filed 2013-03-18 | |
| 2011-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 129.25K shares 10-K · filed 2013-03-18 |
| 2010-12-31 | 10.50K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |